Comparison between Intra-Aortic Balloon Pump and Levosimendan as Treatment Modalities for Cardiogenic Shock Post Cardiac Surgery
DOI:
https://doi.org/10.47672/ajhmn.1347Keywords:
Cardiogenic shock, levosimendan, intra-aortic balloon pump.Abstract
Purpose: Post cardiac surgery cardiogenic shock is one of the major life threatening complications of open heart surgeries. Two modalities are widely used to improve the cardiac output and overcome the acute postoperative complication beside other conventional treatment including mechanical ventilator, inotropes and vasopressors. Those modalities are levosimendan and Intra-aortic balloon pump. The purpose of this study is to investigate the prognosis of levosimendan vs IABP in patients who developed cardiogenic shock post cardiac surgery.
Methodology: This was a prospective observational study conducted as national heart institute, Egypt on 50 patients who developed cardiogenic shock post cardiac surgery and managed by either levosimendan or Intra-aortic balloon Pump (IABP) beside other conventional therapies. Patients were then divided into two groups according to the modality used. Group I: patients who were managed by levosimendan and group II: patients who were managed by IABP. Two groups were then compared according to baseline preoperative characteristics and in-hospital course and one month follow up post discharge echocardiography.
Findings: No significant difference regarding between in-hospital mortality between levosimendan, 44% and IABP, 52% P value 0.5. Levosimendan was associated with significantly shorter ICU stay, 5.56±2.85 compared to IABP, 8±3.34 days (P value 0.02). Levosimendan seems to be a better option than IABP or at least equivalent to it in postoperative cardiogenic shock.
Recommendations: Levosimendan is an alternative cost effective modality for patients with post-operative low cardiac output syndrome especially when IABP isn’t available.
Downloads
References
Vallabhajosyula, S., Arora, S., Sakhuja, A., et al., (2019). Trends, predictors, and outcomes of temporary mechanical circulatory support for postcardiac surgery cardiogenic shock. The American Journal of Cardiology, 123(3), 489–497.
Brener, M. I., Rosenblum, H. R., & Burkhoff, D. (2020). Pathophysiology and advanced hemodynamic assessment of cardiogenic shock. Methodist DeBakey Cardiovascular Journal, 16(1), 7.
Herpain, A., Bouchez, S., Girardis, M., et al., (2019). Use of levosimendan in intensive care unit settings: an opinion paper. Journal of Cardiovascular Pharmacology, 73(1), 3.
Kimman, J. R., Van Mieghem, N. M., Endeman, H., et al., (2020). Mechanical support in early cardiogenic shock: what is the role of intra-aortic balloon counterpulsation? Current Heart Failure Reports, 17(5), 247–260.
Jannati, M., & Attar, A. (2019). Intra-aortic balloon pump postcardiac surgery: A literature review. Journal of Research in Medical Sciences: The Official Journal of Isfahan University of Medical Sciences, 24.
Tehrani, B. N., Truesdell, A. G., Sherwood, M. W., et al., (2019). Standardized team-based care for cardiogenic shock. Journal of the American College of Cardiology, 73(13), 1659–1669.
Alonso, A., Lopez, F. L., Matsushita, K., et al., (2011). Chronic kidney disease is associated with the incidence of atrial fibrillation: the Atherosclerosis Risk in Communities (ARIC) study. Circulation, 123(25), 2946–2953.
Chetrit, M., Roujol, S., Picard, M. H., et al., (2019). Optimal technique for measurement of linear left ventricular dimensions. Journal of the American Society of Echocardiography, 32(4), 476–483.
Parab, S., & Bhalerao, S. (2010). Choosing statistical test. International Journal of Ayurveda Research, 1(3), 187.
Jafari, M., & Ansari-Pour, N. (2019). Why, when and how to adjust your P values? Cell Journal (Yakhteh), 20(4), 604.
Mate, R., Shaikh, N., Raut, C., et al., (2020). Comparison of prophylactic levosimendan versus intra-aortic balloon pump for off-pump coronary artery bypass grafting in patients with low ejection fraction: A randomized-controlled trial. Cardiovasc Surg Int, 7(3), 121–128.
Severi, L., Lappa, A., Landoni, G., et al., (2011). Levosimendan versus intra-aortic balloon pump in high-risk cardiac surgery patients. Journal of Cardiothoracic and Vascular Anesthesia, 25(4), 632–636.
Omar, A., Eldegwy, M., Allam, M., et al., (2020). Comparison of levosimendan versus IABP in patients with poor left ventricular function undergoing coronary artery bypass graft surgery. Heart Surg Forum, 23(1), E093–E097.
Treskatsch, Acs., Balzer, F., Geyer, T., et al., (2015). Early levosimendan administration is associated with decreased mortality after cardiac surgery. Journal of Critical Care, 30(4), 859-e1.
Parissis, H., Leotsinidis, M., Akbar, M. T., et al., (2010). The need for intra aortic balloon pump support following open heart surgery: risk analysis and outcome. Journal of Cardiothoracic Surgery, 5(1), 1–7.
Fernandez-Zamora, M. D., Gordillo-Brenes, A., Banderas-Bravo, E., et al., (2018). Prolonged mechanical ventilation as a predictor of mortality after cardiac surgery. Respiratory Care, 63(5), 550–557.
Salem, R., Denault, A. Y., Couture, P., et al., (2006). Left ventricular end-diastolic pressure is a predictor of mortality in cardiac surgery independently of left ventricular ejection fraction. BJA: British Journal of Anaesthesia, 97(3), 292–297.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Mohamed Said Darwish, Saad Mahmoud Ammar, Yasser Hosny Abdel Rahman, Mahmoud Helmy Alsayed
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution (CC-BY) 4.0 License that allows others to share the work with an acknowledgment of the work’s authorship and initial publication in this journal.
